President-elect Donald Trump has chosen health economist Dr. Jay Bhattacharya, a critic of pandemic lockdowns and vaccine ...

By 2035, the medium-term goals include increasing local production to 75% and developing research partnerships to secure approval for additional vaccines ...

India presently represents 3-4% of global biosimilar production, second to China and aims to increase it significantly. With ...

SINGAPORE — French pharmaceutical giant Sanofi on Wednesday opened a 800 million Singapore dollar ($595 million) "evolutive ...